MedPath

H. Lee Moffitt Cancer Center and Research Institute, Inc.

H. Lee Moffitt Cancer Center and Research Institute, Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors

Not Applicable
Completed
Conditions
Young Adult
Cancer Survivor
Interventions
Behavioral: Cognitive-Behavioral Stress Management and Health Education
First Posted Date
2021-09-17
Last Posted Date
2023-04-14
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
17
Registration Number
NCT05048316
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Wet Heparinized Suction for Abdominal Cancer

Not Applicable
Not yet recruiting
Conditions
Cancer of Pancreas
Cancer
Cancer of Esophagus
Cancer of Stomach
Cancer of Liver
Interventions
Other: wet heparinzed suction
Other: No microsieve
Other: No heparin flush
Other: Microsieve
First Posted Date
2021-09-13
Last Posted Date
2025-04-22
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
42
Registration Number
NCT05041335
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML

Phase 1
Recruiting
Conditions
Acute Myeloid Leukemia With FLT3/ITD Mutation
Interventions
First Posted Date
2021-08-27
Last Posted Date
2025-05-21
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
22
Registration Number
NCT05024552
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Automated Video-Assisted Smoking Treatment for People Living With HIV

Not Applicable
Active, not recruiting
Conditions
Smoking Cessation
Interventions
Behavioral: Counseling
Behavioral: Smartphone-delivered automated treatment
First Posted Date
2021-08-20
Last Posted Date
2025-04-17
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
638
Registration Number
NCT05014282
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Phase 1
Active, not recruiting
Conditions
Acute Myeloid Leukemia
Interventions
First Posted Date
2021-08-20
Last Posted Date
2025-04-17
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
32
Registration Number
NCT05015426
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers

Not Applicable
Active, not recruiting
Conditions
Smoking Cessation
Interventions
Behavioral: Smartphone-delivered automated treatment
Behavioral: Counceling
First Posted Date
2021-08-13
Last Posted Date
2025-04-17
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
520
Registration Number
NCT05004662
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Axitinib + Ipilimumab in Advanced Melanoma

Phase 2
Recruiting
Conditions
Melanoma
Interventions
First Posted Date
2021-08-09
Last Posted Date
2025-05-07
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
25
Registration Number
NCT04996823
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

Completed
Conditions
Colorectal Cancer
Hepatitis C Virus Infection
Interventions
Behavioral: CARES-HCV
First Posted Date
2021-07-28
Last Posted Date
2023-01-23
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
39
Registration Number
NCT04980157
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Completed
Conditions
HPV Vaccine
HPV
Interventions
Behavioral: Interviews
Behavioral: Online survey
Behavioral: Focus groups or Individual Interviews
First Posted Date
2021-07-23
Last Posted Date
2024-06-04
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
155
Registration Number
NCT04974619
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

🇵🇷

Ponce Health Sciences University, Ponce, Puerto Rico

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Phase 1
Recruiting
Conditions
Cutaneous Squamous Cell Carcinoma
Merkel Cell Carcinoma
Interventions
First Posted Date
2021-07-23
Last Posted Date
2025-05-20
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
30
Registration Number
NCT04975152
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath